Verapamil Hydrochloride Capsule, Delayed Release
Product Images NDC 52536-882

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 52536-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wilshire Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (120 mg Capsule Bottle Label)

This text provides information about Verapamil Hydrochloride sustained-release capsules in a strength of 120 mg. The medication is intended for use by adults only and should be stored at controlled room temperature. The capsules are to be dispensed in a light-resistant container as per USP guidelines. The manufacturing details and distribution information are also included in the text.*

FDA Label Image

Principal Display Panel (180 mg Capsule Bottle Label)

This is a description of Verapamil Hydrochloride Sustained-Release Capsules containing 180 mg of the active ingredient. The medication is intended for adults and should be stored at controlled room temperature. It is manufactured by Societal CDMO Gainesville, LLC and distributed by Wilshire Pharmaceuticals, Inc. The package includes 100 capsules and must be dispensed in a tight, light-resistant container. For detailed dosage instructions, refer to the package insert.*

FDA Label Image

Principal Display Panel (240 mg Capsule Bottle Label)

This is a description of Verapamil Hydrochloride Sustained-Release Capsules, each containing 240 mg of verapamil hydrochloride. The medication is intended for adult use only and should be dispensed in a light-resistant container. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with protection from excessive heat and moisture. The manufacturer is Societal CDMO Gainesville, LLC, with the capsules distributed by Wishire Pharmaceuticals, Inc. The package contains 100 capsules and the prescription is required for purchase. For specific dosage instructions and prescribing information, consult the package insert.*

FDA Label Image

Principal Display Panel (360 mg Capsule Bottle Label)

This text provides detailed information about Verapamil Hydrochloride Sustained-Release Capsules. Each capsule contains 360 mg of Verapamil Hydrochloride. It is a prescription medication and should be dispensed in a tight, light-resistant container. The usual adult dosage and prescribing information can be found in the package insert. It should be stored at Controlled Room Temperature (20°C to 25°C) to avoid moisture and excessive heat. The medication is manufactured by Societal CDMO Gainesville, LLC in Gainesville, GA, USA, and distributed by Wilshire Pharmaceuticals, Inc. in Atlanta, GA, USA. The revision date of this information is 09/2024.*

FDA Label Image

Verapamil Hydrochloride Structural Formula (Verapamil 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.